Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Repligen appoints Robert Spurr senior VP and CCO

This article was originally published in Scrip

Executive Summary

Robert Spurr has joined Repligen Corporation as senior vice-president of sales and marketing and chief commercial officer. Mr Spurr will be responsible for establishing the commercial organisation to sell SecreFlo (secretin) in the US (pending FDA approval) and overseeing the commercial operations of the company's bioprocessing business. He previously served as vice-president of sales and marketing for Ortho-McNeil, a division of Johnson and Johnson.

Advertisement
Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC014049

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel